Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy
Open Access
- 24 March 2024
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 557, 117888
Abstract
No abstract availableKeywords
Funding Information
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
This publication has 36 references indexed in Scilit:
- Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational studyFree Radical Biology and Medicine, 2022
- CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in miceInflammation Research, 2022
- CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vγ4+ γδ T cellsJournal of Autoimmunity, 2019
- Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patientsHuman Immunology, 2018
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working GroupKidney International, 2017
- Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 ImmunityCell Reports, 2017
- A Th17/Lymphotoxin axis enables cytokine production by brain meningeal stromal cells and propagates de novo CNS-intrinsic T cell responses during inflammationJournal of Neuroimmunology, 2014
- In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30+T cellsImmunology Letters, 2014
- The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic valueClinical Rheumatology, 2006
- CD30: expression and function in health and diseaseSeminars in Immunology, 1998